Literature DB >> 28752324

Effect of Glucose on 3D Cardiac Microtissues Derived from Human Induced Pluripotent Stem Cells.

Michael Balistreri1, Justin A Davis2,3,4,5, Katherine F Campbell3, André Monteiro Da Rocha3, Marjorie C Treadwell2, Todd J Herron3,4,5.   

Abstract

Maternal hyperglycemia is a risk factor for fetal cardiac anomalies. This study aimed to assess the effect of high glucose on human induced pluripotent stem cell-derived cardiomyocyte self-assembly into 3D microtissues and their calcium handling. Stem cells were differentiated to beating cardiomyocytes using established protocols. On the final day of the differentiation process, cells were treated with control media, 12 mM glucose, or 12 mM mannitol (an osmolality control). Once beating, the cardiac cells were dissociated with trypsin, collected, mixed with collagen, and plated into custom-made silicone micro molds in order to generate 3D cardiac microtissues. A time-lapse microscope took pictures every 4 h to quantify the kinetics of cellular self-assembly of 3D cardiac tissues. Fiber widths were recorded at 4-h intervals and plotted over time to assess cardiomyocyte 3D fiber self-assembly. Microtissue calcium flux was recorded with optical mapping by pacing microtissues at 0.5 and 1.0 Hz. Exposure to high glucose impaired the ability of cardiomyocytes to self-assemble into compact microtissues, but not their ability to spontaneously contract. Glucose-exposed cardiomyocytes took longer to self-assemble and finished as thicker fibers. When cardiac microtissues were paced at 0.5 and 1.0 Hz, those exposed to high glucose had altered calcium handling with shorter calcium transient durations, but larger amplitudes of the calcium transient when compared to controls. Additional studies are needed to elucidate a potential mechanism for these findings. This model provides a novel method to assess the effects of exposures on the cardiomyocytes' intrinsic abilities for organogenesis in 3D.

Entities:  

Keywords:  Cardiac microtissue; Cardiomyocyte; Glucose; Hyperglycemia; Pluripotent stem cell

Mesh:

Substances:

Year:  2017        PMID: 28752324     DOI: 10.1007/s00246-017-1698-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  31 in total

Review 1.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  In vivo cardiac electrophysiology studies in the mouse.

Authors:  C I Berul; M J Aronovitz; P J Wang; M E Mendelsohn
Journal:  Circulation       Date:  1996-11-15       Impact factor: 29.690

3.  Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure.

Authors:  J J Mercadier; A M Lompré; P Duc; K R Boheler; J B Fraysse; C Wisnewsky; P D Allen; M Komajda; K Schwartz
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

Review 4.  Dynamic interactions between myocytes, fibroblasts, and extracellular matrix.

Authors:  Indroneal Banerjee; Krishna Yekkala; Thomas K Borg; Troy A Baudino
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

5.  Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-01-19       Impact factor: 17.586

6.  Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells.

Authors:  Guihua Jiang; Todd J Herron; Julie Di Bernardo; Kendal A Walker; K Sue O'Shea; Shaun M Kunisaki
Journal:  Stem Cells Transl Med       Date:  2016-07-27       Impact factor: 6.940

7.  First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy.

Authors:  M F Greene; J W Hare; J P Cloherty; B R Benacerraf; J S Soeldner
Journal:  Teratology       Date:  1989-03

8.  Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure.

Authors:  T Takahashi; P D Allen; R V Lacro; A R Marks; A R Dennis; F J Schoen; W Grossman; J D Marsh; S Izumo
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway.

Authors:  Yibing Qyang; Silvia Martin-Puig; Murali Chiravuri; Shuibing Chen; Huansheng Xu; Lei Bu; Xin Jiang; Lizhu Lin; Anne Granger; Alessandra Moretti; Leslie Caron; Xu Wu; Jonathan Clarke; Makoto M Taketo; Karl-Ludwig Laugwitz; Randall T Moon; Peter Gruber; Sylvia M Evans; Sheng Ding; Kenneth R Chien
Journal:  Cell Stem Cell       Date:  2007-06-14       Impact factor: 24.633

10.  Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants.

Authors:  T J Lints; L M Parsons; L Hartley; I Lyons; R P Harvey
Journal:  Development       Date:  1993-10       Impact factor: 6.868

View more
  5 in total

1.  Phenotypic Variation Between Stromal Cells Differentially Impacts Engineered Cardiac Tissue Function.

Authors:  Tracy A Hookway; Oriane B Matthys; Federico N Mendoza-Camacho; Sarah Rains; Jessica E Sepulveda; David A Joy; Todd C McDevitt
Journal:  Tissue Eng Part A       Date:  2019-05       Impact factor: 3.845

2.  hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen.

Authors:  André Monteiro da Rocha; Katherine Campbell; Sergey Mironov; Jiang Jiang; Lakshmi Mundada; Guadalupe Guerrero-Serna; José Jalife; Todd J Herron
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

Review 3.  Environmental Alterations during Embryonic Development: Studying the Impact of Stressors on Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Federica Lamberto; Irene Peral-Sanchez; Suchitra Muenthaisong; Melinda Zana; Sandrine Willaime-Morawek; András Dinnyés
Journal:  Genes (Basel)       Date:  2021-09-30       Impact factor: 4.096

Review 4.  A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes.

Authors:  Razan Elfadil Ahmed; Tatsuya Anzai; Nawin Chanthra; Hideki Uosaki
Journal:  Front Cell Dev Biol       Date:  2020-03-19

Review 5.  Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells.

Authors:  Emma Claire James; Eva Tomaskovic-Crook; Jeremy Micah Crook
Journal:  Int J Mol Sci       Date:  2021-03-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.